OTHER INFORMATION.
−Removed: The documents listed below are incorporated by reference or are filed with this Quarterly Report, in each case as indicated therein (numbered in accordance with Item 601 of Regulation S‑K).
+Added: The documents listed below are incorporated by reference or are filed or furnished with this Quarterly Report, in each case as indicated therein (numbered in accordance with Item 601 of Regulation S‑K).
Number Description of Exhibit
2 unchanged sentences
(f/k/a ImmunityBio, Inc.) and Nectarine Merger Sub, Inc.
−Removed: (incorporated by reference to Exhibit 2.1 to the company’s Current Report on Form 8-K filed with
−Removed: the SEC on December 22, 2020).
−Removed: 10.1†† Purchase Agreement, by and between Athenex, Inc.
−Removed: and ImmunityBio, Inc.
−Removed: dated as of January 7, 2022
−Removed: (incorporated by reference to Exhibit 10.1 to the company’s Current Report on Form 8-K filed
−Removed: with the SEC on January 12, 2022).
−Removed: 10.2 Fort Schuyler Management Corporation Lease, effective as of October 1, 2021, between Fort Schuyler
−Removed: Management Corporation, as Landlord, and Athenex, Inc., as Tenant ( inco rpor a ted by reference to
−Removed: Exhibit 10.2 to the company ’ s Qua rterly R eport on Form 10-Q filed with the SEC on May 10, 2022) .
−Removed: 10.3 First Amendment to Lease, effective as of February 14, 2022, by and among Fort Schuyler Management
−Removed: Corporation and Immunity, Bio, Inc.
−Removed: (incorporated by reference to Exhibit 10.3 to the company's
−Removed: Quarterly Report on Form 10-Q filed with the SEC on May 10, 2022).
−Removed: 10.4* Second Amendment to Facility License Agreement, effective as of May 1, 2022, by and between NantWorks, LLC, the Licensor, and ImmunityBio, Inc., the Licensee.
−Removed: 10.5* Industrial/Commercial Lease Agreement dated May 1, 2022 by and between 23 Alaska, LLC and ImmunityBio, Inc.
−Removed: 10.6* First Amendment to Lease dated July 16, 2015 by and between ARE-JOHN HOPKINS COURT, LLC and Conkwest, Inc.
−Removed: 10.7* Second Amendment to Lease effective as of June 18, 2016 by and between ARE-JOHN HOPKINS COURT, LLC and NantKwest, Inc., fka Conkwest, Inc.
−Removed: 10.8* Third Amendment to Lease dated April 12, 2022 by and between ARE-JOHN HOPKINS COURT, LLC and ImmunityBio, Inc.
−Removed: 10.9* Lease Termination Agreement effective May 31, 2022 by and between ImmunityBio, Inc.
−Removed: and 557 Doug St., LLC.
+Added: (incorporated by reference to Exhibit 2.1 to the company’s Current Report on Form 8-K filed with the SEC on December 22, 2020).
+Added: 10.1* Promissory Note between ImmunityBio, Inc.
+Added: and Nant Capital, LLC dated August 31, 2022.
+Added: 10.2* Amended and Restated Promissory Note between ImmunityBio, Inc.
+Added: and Nant Capital, LLC dated August 31, 2022.
+Added: 10.3* Amended and Restated Convertible Promissory Note between ImmunityBio, Inc.
+Added: and Nant Capital, LLC dated August 31, 2022.
+Added: 10.4* Amended and Restated Convertible Promissory Note between ImmunityBio, Inc.
+Added: and Nant Capital, LLC dated August 31, 2022.
+Added: 10.5* Second Amended and Restated Convertible Promissory Note between ImmunityBio, Inc.
+Added: and Nant Capital, LLC dated August 31, 2022.
+Added: 10.6* Second Amended and Restated Convertible Promissory Note between ImmunityBio, Inc.
+Added: and NantWorks, LLC dated August 31, 2022.
+Added: 10.7* Second Amended and Restated Convertible Promissory Note between ImmunityBio, Inc.
+Added: and NantCancerStemCell, LLC dated August 31, 2022.
+Added: 10.8* Second Amended and Restated Convertible Promissory Note between ImmunityBio, Inc.
+Added: and NantMobile, LLC dated August 31, 2022.
31.1* Rule 13a-14(a) / 15(d)-14(a) Certification of Principal Executive Officer.
13 unchanged sentences
The company agrees to furnish to the SEC a copy of any omitted schedule or exhibit upon request.
−Removed: †† Schedules and similar attachments have been omitted pursuant to Item 601(a)(5) of Regulation S-K.
−Removed: The company agrees to furnish to the SEC a copy of any omitted schedule or similar attachment upon request.
* Filed herewith.
3 unchanged sentences
IMMUNITYBIO, INC.
−Removed: August 8, 2022
+Added: November 8, 2022
/s/ Richard Adcock
2 unchanged sentences
(Principal Executive Officer)
−Removed: August 8, 2022
+Added: November 8, 2022
Chief Financial Officer
1 unchanged sentence
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.